[Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy]

Diabetes Metab. 1998 Feb;24(1):80-4.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Administration Schedule
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Insulin